Blake Insomnia Therapeutics Inc and Sajo Consulting LLC announce the team appointed to conduct clinical trials of its insomnia products using Blake’s Zleepax formula.

Christian Schutz, medical director

Schutz received an MD from Albert Ludwigs University in Freiburg, Germany, a PhD from Ludwig Maximilians University in Munich and a Master of Public Health from Johns Hopkins University. He held a Fellowship in Behavioral Pharmacology from the National Institute on Drug Abuse at the National Institutes of Health in Baltimore and, while on sabbatical, studied Clinical Neuroscience at Yale University. He currently serves as an associate professor at UBC’s Faculty of Medicine in the Department of Psychiatry.

Ajit Johal, clinical trial sponsor

Johal is a graduate from the Leslie Dan Faculty of Pharmacy at the University of Toronto. He is the clinical services coordinator at Wilson Pharmacy in Port Coquitlam and is a clinical instructor at UBC’s Faculty of Pharmaceutical Sciences. He has worked as lead clinical pharmacist for a number of outreach programs including the Integrated Medication Management Program and the Coast Mental Health Medication Program.

Anastasia Frank, research coordinator

Frank holds a Master of Public Health from the University of British Columbia and a BA with Honors in Geography from McGill University. Her focus is expanding the links between urban planning and public health. She has worked on a number projects both in and out of the lab.

Canadian clinical trials are planned for Q3 2017 pending approval of a New Drug Submission by the Health Products and Food Branch of Health Canada.